Market Overview
In a day marked by geopolitical tensions and sector-specific volatility, the markets closed with a palpable sense of urgency as investors grappled with the interplay of macroeconomic forces and corporate developments. The escalation of US-Iran tensions, underscored by a surge in attacks on ships traversing the Strait of Hormuz, has reignited concerns over energy security and contributed to a spike in crude oil prices. This geopolitical instability, coupled with persistent inflationary pressures, has left investors navigating a complex landscape as they assess the implications for global markets. On the corporate front, the banking sector presented a mixed picture. While major banks like JPMorgan Chase, Goldman Sachs, Citigroup, and Wells Fargo reported robust earnings, driven by a significant uptick in equities trading, the higher yield environment has tempered enthusiasm. The bond trading desks, traditionally a cornerstone of Wall Street's revenue, have been overshadowed by their equities counterparts, reflecting a broader shift in market dynamics. This transition underscores the challenges posed by rising interest rates, which have dampened bond trading activity and raised borrowing costs, complicating the landscape for private equity firms struggling to realize profits on their investments. The semiconductor sector also faced headwinds, with memory stocks taking a hit amid concerns over competitive pressures. The announcement by China's leading memory manufacturer, CXMT, about advancements in cutting-edge chip technology has intensified fears of a competitive disadvantage for U.S. firms like Micron Technology and SK Hynix. This development highlights the ongoing technological race and its implications for market leadership in the semiconductor industry. Energy stocks, meanwhile, have been buoyed by the geopolitical tensions in the Middle East, with crude oil prices climbing as the situation in the Persian Gulf remains precarious. The attacks on tankers in the Strait of Hormuz have not only threatened the stability of oil exports but have also underscored the vulnerability of global supply chains to regional conflicts. As investors look ahead, the focus will be on upcoming inflation data and the Federal Reserve's policy decisions. With the central bank's benchmark rate already elevated to combat inflation, the market is keenly attuned to any signals regarding future rate hikes. The interplay between inflationary pressures, geopolitical risks, and corporate earnings will continue to shape the investment landscape, leaving investors to navigate a path through uncertainty. In summary, today's market session was defined by a confluence of geopolitical volatility, sector-specific rotations, and corporate developments, leaving investors with a complex set of challenges as they prepare for the days ahead. The urgency of the situation is palpable, as the macroeconomic environment and micro-level corporate outcomes continue to evolve in an unpredictable global landscape.
In today's after-hours trading, the US stock market was significantly influenced by geopolitical tensions and sector-specific developments. The escalation of US-Iran tensions, marked by attacks on ships in the Strait of Hormuz, has heightened concerns over energy security, driving crude oil prices higher. This geopolitical instability has notably buoyed energy stocks, as evidenced by the XLE ETF's 1.8% gain, reflecting investor sentiment towards energy security amidst regional conflicts. Conversely, the banking sector presented a mixed picture. Despite robust earnings from major banks like JPMorgan Chase and Goldman Sachs, driven by a surge in equities trading, the higher yield environment has tempered enthusiasm. This is reflected in the XLF ETF's 0.4% decline, as rising interest rates have dampened bond trading activity, a traditional revenue source for banks. The semiconductor sector faced headwinds due to competitive pressures, particularly from China's CXMT, which announced advancements in chip technology. This has intensified fears of a competitive disadvantage for US firms, contributing to the XLK ETF's slight 0.06% decline. Investors are wary of the ongoing technological race and its implications for market leadership. On the broader market front, persistent inflationary pressures and the Federal Reserve's policy decisions remain focal points. The XLU ETF's 0.6% gain suggests a cautious optimism towards utilities, often seen as a defensive play in uncertain times. However, the XLV healthcare ETF's 1.4% drop indicates sector-specific concerns, possibly linked to broader economic uncertainties. As investors look ahead, the interplay between inflation, geopolitical risks, and corporate earnings will continue to shape the investment landscape. The urgency of navigating this complex environment is palpable, with market sentiment likely to remain volatile in the coming sessions.
Market Insights
U.S. equities edged higher in subdued trading, with the advance largely driven by tech megacaps, while broader market participation waned. More than two-thirds of gainers advanced on below-average volume, indicating that institutional desks remained largely on the sidelines despite the green tape. Volume divergence was evident as below-average volume gainers showed positive returns, while above-average volume decliners exhibited negative returns, suggesting a lack of institutional participation in advancers. This divergence highlights a market that is heavily reliant on a few large-cap stocks, with broader participation dwindling. High-beta stocks did the heavy lifting, outperforming defensive cohorts as the median stock managed just modest gains. Under light volume, market fragility became apparent, with high-beta stocks underperforming and highlighting increased risk during low-volume periods. While market breadth superficially favored bulls, the absence of volume confirmation leaves the market vulnerable to sharp reversals if macroeconomic headlines trigger sudden selling. This fragility underscores the importance of monitoring volume trends and macroeconomic developments closely.
Next Day Option Data
QQQ
SPY
IWM
6-K/8-K Form Update
RWTO
Redwood Trust, Inc. announced its third quarter 2026 financial results, scheduled for release on November 3, 2026. The company distributed over $8 billion in mortgage loans through securitizations and whole loan sales, maintaining a cash position of approximately $190 million. Redwood Trust will hold a conference call on November 3 at 5:00 p.m. Eastern Time to discuss financial results and strategic priorities, including capital structure management and opportunistic debt repurchases.
PREM
Premier Air Charter Holdings Inc. terminated its Exclusive Aircraft Lease Agreements with AB Jet Co I, LLC and AB Jet Co VI, LLC for two Cessna Citation CJ3 aircraft, following a default notice for non-payment and maintenance failures. The Lessors claim approximately $514,557 is due, including accelerated principal and unpaid rent, which Premier disputes. As a result, Premier ceased operations of its CJ-series aircraft and reduced its workforce from 42 to 37 employees, while negotiations with the Lessors continue to resolve the outstanding amounts.
DAICW
CID HoldCo, Inc. completed the acquisition of Envoy Technologies, Inc. for 100% of Envoy's outstanding capital stock, exchanging shares of Common Stock and Series C Convertible Non-Redeemable Preferred Stock. The transaction involved 10,833,333 shares of Common Stock and 8,433,123 shares of Series C Preferred Stock, with an outstanding Envoy Convertible Note of $12,500,000. The Blink Conversion Conditions require shareholder approval for Nasdaq listings and SEC registration of Blink Conversion Shares.
BRLL
Barrel Energy, Inc. announced the launch of Almighty Cleaners, an eco-friendly line of cleaners and degreasers, under its Happy Traps business, set for market introduction in October 2026. The initiative marks a strategic shift from waste collection to product commercialization, utilizing recovered materials. The company highlighted forward-looking statements regarding market introduction, subject to risks such as production capacity and customer acceptance.
POLA
Polar Power, Inc. announced a new management structure effective October 6, 2026, appointing Chris Mayer as Co-CEO responsible for corporate strategy, financial performance, and investor relations, while Arthur Sams will continue as Co-CEO and President overseeing sales, engineering, manufacturing, and operations. Mayer, joining with extensive experience in manufacturing and finance, previously led CM Capital Management, LLC, CM Fabrication, LLC, and Windows Distillery, LLC, and will serve on Polar Power's Board through CL Investment Group LLC, which owns 50% of CL Investment.
UUUU
Energy Fuels Inc. amended its merger agreement with Ara VAC Group B.V. and related entities, incorporating new financial terms. The amendment includes the definition of "Credit Agreement" and introduces the "e-VAC Repayment Amount," which Parent will pay to the Administrative Agent on behalf of Secured Parties. Changes also involve payment of Cash Consideration via Wire Transfer and updates to several sections, including the addition of the e-VAC Repayment Amount as a separate clause.
PRCH
Porch Group, Inc. agreed to acquire Allied Trust Insurance Company and related entities through its subsidiary, Homeowners of America Holding Corporation, for a total consideration of $200 million, subject to adjustments. The transaction involves $105 million for ATIC shares and $95 million for AU MGA and Lonestar membership interests, with potential equity and cash payments. The deal, pending Texas Department of Insurance approval, is expected to close in the first quarter of 2027.
BUSEP
First Busey Corporation declared a quarterly cash dividend of $0.26 per share, payable on October 30, 2026, to stockholders of record as of October 23, 2026. The company filed a Form 8-K on October 13, 2026, to disclose the dividend declaration, fulfilling its obligations under Rule 425 of the Securities Act. As a Nasdaq-listed entity, First Busey Corporation's compliance with Nasdaq regulations remains unspecified in this filing.
HYMCW
Hycroft Mining Holding Corporation announced groundbreaking drill results from its 2025-2026 Exploration Drill Program, revealing the highest-grade intercept in the company's history. Hole H26D-6175A intersected 19.6 meters at 30.49 g/t gold and 1,726.72 g/t silver, including 1.7 meters at 347.07 g/t gold and 9,526.36 g/t silver, marking the best hole ever drilled in Hycroft's over 40-year history. Follow-up drilling is underway to further explore the Vortex and Brimstone systems, suggesting proximity to a potential source of mineralization.
BYSI
BeyondSpring Inc. ratified CBIZ CPAs P.C. as its independent registered public accounting firm for the fiscal year ending December 31, 2026, with a shareholder vote of 20,810,814 in favor. The company announced Min Qiu as its new Chief Executive Officer, effective October 13, 2026, succeeding the former CEO. BeyondSpring Inc. completed a $150 million acquisition of assets from a competitor on October 10, 2026, pending regulatory approval, while addressing a shareholder lawsuit alleging financial misrepresentation, currently under litigation review.
MUX
McEwen Inc. has agreed to sell non-core assets to Dome Mine Ltd., a subsidiary of Discovery Mining Ltd., for $55 million, comprising $5 million in cash and $50 million in Discovery shares. The transaction, which includes the Fuller and Paymaster properties in Timmins, Ontario, will provide McEwen with additional capital to invest in its operations and development projects. The deal is expected to close following customary conditions, including TSX approval, and is part of McEwen's strategy to produce 250,000-300,000 gold equivalent ounces annually by 2030 with minimal share dilution.
VTAK
Flyte Aviation, Inc. (NYSE American: VJET) reported record preliminary third-quarter 2026 revenue of approximately $2.15 million, marking a 110% increase quarter-over-quarter. The company's Aviation segment revenue surged 150% to about $1.87 million, while MedTech revenue grew 24% year-over-year and 4% sequentially to roughly $280,000. Flyte's redesigned direct-to-consumer booking platform added over 13,000 new accounts, boosting its user base by 185% to more than 20,000, with direct-to-consumer revenue surpassing $500,000 in the quarter.
ZPTAW
Zapata Quantum, Inc. secured compliance with national securities exchange listing requirements by approving a reverse stock split at its 2026 Annual Meeting of Stockholders. Shareholders also ratified Weinberg & Company as the independent registered public accounting firm for the year ending December 31, 2026, and elected three directors for one-, two-, or three-year terms. The meeting, attended by 148.46 million votes, also approved executive compensation on a non-binding basis and recommended a three-year frequency for future advisory votes on executive compensation.
QUMSR
Quantumsphere Acquisition Corporation (QUMS) has agreed to merge with Fortune Favor Technology Inc. (the Company) through a Merger Agreement with Fortune Favor Global Group Inc. (Purchaser), with Purchaser surviving as the surviving entity. Upon the merger's effective time, QUMS shares will convert into Purchaser shares, and Company shares will be exchanged for a portion of Purchaser shares valued at $10 each, based on a pre-money valuation of approximately $600 million. The transactions are contingent on customary closing conditions, including shareholder approvals and regulatory clearances.
SFCX
SUPA Consolidated Inc. dismissed Lao Professionals as its independent registered public accounting firm, effective October 7, 2026, due to a strategic shift towards U.S.-based firms for better access to management and operations. The company identified material weaknesses in its internal control over financial reporting as of December 31, 2025, including a lack of segregation of duties and inadequate governance. The Board approved Simon & Edward, LLP, a PCAOB-registered firm, to audit the fiscal year ending December 31, 2026, and review the interim statements for the quarter ending September 30, 2026.
MRK
Merck & Co., Inc. has secured a new board member, Paul J. Diaz, effective November 1, 2026, with shareholder election in May 2027, expanding the board to 14 members. Diaz, with extensive leadership experience in healthcare, previously served as president and CEO of Myriad Genetics, Inc., and Kindred Healthcare, and currently serves on the boards of Centene Corporation, Johns Hopkins Medicine, and Georgetown University Law Center. Merck, known as MSD outside the U.S. and Canada, is a biopharmaceutical company focused on innovative health solutions, listed on the NYSE under the ticker symbol MRK.
LKFN
Lakeland Financial Corporation declared a quarterly cash dividend of $0.52 per share, payable on November 5, 2026, to shareholders of record on October 25, 2026. The company's Board of Directors approved the repurchase of up to $50 million of its common stock under a new share repurchase program, effective immediately. The program will be executed through open market purchases or tender offers, contingent on market conditions and other factors, and is subject to compliance with applicable laws and regulations.
PG
Procter & Gamble declared a quarterly dividend of $1.0885 per share on its Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock, payable on November 16, 2026, to shareholders of record by October 23, 2026. The company's twelve Director nominees were elected to the Board of Directors at the Annual Meeting of Shareholders, receiving strong support. This filing includes an 8-K report under Regulation FD Disclosure regarding the dividend and election results.
CVAT
Cavitation Technologies, Inc. agreed to replace prior tender offer agreements with BrightFlixx Finance (Luxembourg) S.A. for its shares and those of Alchemy Beverages Inc., in which it holds a 17% stake. The new agreements propose cash tender offers for outstanding shares at aggregate purchase prices of $35 million and $7 million, respectively, contingent on regulatory approval and completion of the counterpart tender offer. BrightFlixx expects to file necessary statements with the SEC once available.
SKYAW
SkyAI has announced its intention to commence a cash tender offer on October 11, 2026, to purchase up to 95% of its outstanding common stock and various warrants at $3.00 per share, a 65% premium over its closing price on October 9, 2026. The offer, contingent on a minimum 50% subscription and SOL price stability above $100, aims to provide liquidity to shareholders and warrant holders. SkyAI plans to fund the offer using cash and proceeds from SOL sales, while suspending its share repurchase program until after the offer concludes.
OTLC
Oncotelic Therapeutics Inc. showcased its PDAOAI platform and hepatocellular carcinoma research at Drug Discovery 2026 in Burlingame, California. The presentations highlighted the platform's search and evidence-aggregation workflow, a four-gene mTOR-related signature linked to overall survival, and an initiative inviting therapeutic research proposals. The company disclosed that the information in its Current Report on Form 8-K is furnished and not deemed "filed" under the Securities Exchange Act of 1934, except as expressly referenced.
PHIO
Phio Pharmaceuticals Corp. achieved a critical operational milestone by successfully completing its first commercial-scale cGMP batch of PH-762 drug substance. This accomplishment marks a strategic advancement as the company progresses PH-762 to the next stage of clinical development. The batch, manufactured in compliance with cGMP regulations and ICH Q7 guidelines, underscores Phio's supply chain readiness and supports its upcoming clinical and regulatory milestones, including the planned Phase 2b study in early 2027.
CRVO
CervoMed Inc. reported promising initial data from its Phase 2a clinical trial in nonfluent variant primary progressive aphasia (nfvPPA), showing a significant reduction in neurofilament light chain (NfL) levels, a key neurodegeneration biomarker. The trial, involving 25 participants, demonstrated an average decline of ~3.1 pg/mL in plasma NfL levels over 12 weeks, with a more pronounced ~5.7 pg/mL decrease in those with higher baseline levels. CervoMed's investigational drug, neflamapimod, targets neuroinflammation and synaptic dysfunction, and has received Fast Track and Orphan Drug Designations from the FDA.
MTVA
MetaVia Inc. appointed Sarah Kaplan Browne, M.D. as Chief Medical Officer, effective October 12, 2026. Dr. Browne, with over 20 years of experience in clinical development and regulatory science, particularly in liver and metabolic diseases, joins from Altimmune, Inc., where she led clinical programs in obesity and metabolic disorders. MetaVia plans to leverage her expertise as they prepare for the anticipated fourth quarter 2026 topline data readout from Part 3 of their Phase 1 clinical trial of DA-1726, evaluating higher target doses, and advancing vanoglipel (DA-1241) for the treatment of MASH.
CRC
California Resources Corporation reported preliminary unaudited financial results for the third quarter ending September 30, 2026, with an estimated realized oil price of $72.46 per barrel, including derivative settlements. The company anticipates a $134 million loss from net settlements of commodity derivatives, comprising $122 million from oil sales and $12 million from natural gas purchases. Forward-looking statements caution that actual results may vary due to risks and uncertainties, including impacts from ongoing commercial and logistics actions.
NWTG
Newton Golf Company, Inc. faces imminent delisting from Nasdaq after failing to maintain the required $2,500,000 in stockholders' equity, as per Nasdaq Listing Rule 5550(b)(1). The company received a deficiency letter on April 6, 2026, and despite submitting compliance plans on May 21 and August 20, 2026, a Staff Determination on October 6, 2026, confirmed non-compliance. Trading is scheduled for suspension on October 15, 2026, unless an appeal is filed by October 13, 2026, with the company planning to request a hearing to stay the suspension pending the Panel's decision.
IBIO
iBio, Inc. announced preclinical results from its obese non-human primate study evaluating IBIO-610, a potentially first-in-class Activin E antibody candidate. The study revealed that lean mass constituted 6% of weight loss with IBIO-610 plus semaglutide, compared to 22% with semaglutide alone, with nearly all weight loss attributed to fat reduction. IBIO-610 demonstrated durable inhibition of active Activin E and a 33.2-day half-life, suggesting potential for twice-yearly dosing in humans. iBio plans to initiate first-in-human studies in the first half of 2027.
JNJ
Johnson & Johnson reported Q3 2026 results, with sales of $25.4 billion, a 5.9% increase year-over-year, and raised its 2026 guidance to $101.2 billion in sales, up 7.4% at the midpoint. The company secured market authorization for OTTAVA, the world's first table-integrated soft tissue robotic system, and FDA approval for IMAAVY, the first treatment for warm autoimmune hemolytic anemia. Strategic moves include acquiring Firefly Bio, Inc., and collaborating with Sail Biomedicines on in vivo CAR-T programs.
MIRM
Mirum Pharmaceuticals, Inc. announced positive topline results from the Phase 3 EXPAND study evaluating LIVMARLI (maralixibat) for treating cholestatic pruritus in pediatric patients with ultra-rare cholestatic liver diseases. The study met its primary endpoint and achieved statistical significance across all secondary endpoints, showing a mean 1.81-point improvement in itch severity compared to placebo. Mirum plans to submit a supplemental New Drug Application in the U.S. in the first half of 2027.
STRK
Strategy Inc issued $21 million in notes through its at-the-market program, using proceeds to purchase bitcoin. The company acquired 250 BTC for $86.194 million, increasing its total holdings to 848,250 BTC. Additionally, Strategy repurchased 3.864 million shares of its preferred stock for $192.4 million, while maintaining $4.88 billion in USD Reserve and $640.5 million in USD Cash as of October 11, 2026.
NOG
Northern Oil and Gas, Inc. (NYSE: NOG) reported preliminary third-quarter 2026 financial results, highlighting operational success across all basins and closing on approximately 1,060 net acres with 2.8 net wells. The company announced capital expenditures between $250.0 and $253.0 million, excluding non-budgeted acquisitions, and declared a $0.45 quarterly cash dividend. Additionally, NOG repurchased 667,989 shares for $16.0 million, with the figures subject to final financial closing procedures.
PBR-A
Petrobras, in partnership with Shell, TotalEnergies, and Petrogal, signed Cost and Volume Balancing Agreements for the Berbigão and Sururu Shared Reservoirs in the Santos Basin. As a result, Petrobras will receive a net amount of approximately US$ 859 million from the BM-S-11A Consortium partners by November 2026. The agreements reconcile production revenues, investment, and operating expenditures, and oil royalties from September 15, 2000, to April 30, 2026.
MI
NFT Limited (Hong Kong) completed three registered direct offerings in October 2026, raising approximately $4.55 million in gross proceeds and $3.865 million in net proceeds. The offerings included 1,890,000 units at $1.35 per Common Unit and 2,000,000 units at $1.00 per Common Unit and $0.96 per Pre-Funded Unit. The company plans to allocate the net proceeds for business development, working capital, and general corporate purposes.
GSL-PB
Global Ship Lease, Inc. has secured a $1 billion syndicated loan facility with an interest rate of SOFR + 1.5% and a seven-year duration. The facility, led by Bank of America and involving an 8-bank syndicate, is structured to fund the delivery of 15 newbuildings announced in June 2026. This financing underscores strong lender confidence and enhances the company's newbuilding program by providing favorable terms.
BHST
BioHarvest Sciences Inc. has achieved commercial readiness for its Olive Cell composition, now available for licensing and commercialization through its CDMO business. The milestone follows the completion of development from plant-cell optimization to large-scale bioreactor scale-up and a self-affirmed U.S. GRAS process. Preliminary data suggests Olive Cell may reduce fatty liver disease progression markers, with up to 37% reduction in intracellular lipid accumulation and up to 50% reduction in collagen type I accumulation, positioning BioHarvest to expand its proprietary asset portfolio through licensing and co-development.
GRPFF
Grupo Televisa, S.A.B. agreed to acquire AT&T Mexico in a joint venture with Fintech Holdings Inc. for US$2 billion, pending regulatory approvals, with a closing expected in Q1 2027. The acquisition, targeting the second-largest mobile operator in Mexico, will be financed through cash and non-recourse secured debt. Televisa plans to account for the transaction as an investment in a joint venture using the equity method under IFRS.
AGMH
AGM Group Holdings Inc. faces imminent delisting from Nasdaq after its Class A ordinary shares' closing bid price fell below $1.00 for 30 consecutive business days, from August 27, 2026, to October 8, 2026. The company has a 180-calendar-day compliance period until April 7, 2027, to regain compliance, with a potential 180-day extension if it meets other initial listing standards. A reverse stock split may be required during the second compliance period.
DPRO
Draganfly Inc. announced a strategic investment in Ukraine's DoD Solution, focusing on advanced drone autonomy technology for global markets. The investment, with an undisclosed value, aims to enhance unmanned systems' capabilities in demanding environments. Draganfly CEO Cameron Chell will join DoD Solution's board to facilitate technology integration and distribution. DoD Solution will use the funds to develop its next-generation AURA SBC and advance AURA OS and AI capabilities, aligning with U.S. defense compliance.
BBVXF
Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) has agreed to execute a second tranche of its share buyback program under the New Program Scheme 1. The program allows BBVA to reduce its share capital by cancelling shares acquired, with a maximum cash amount of up to EUR 1,000 million and a maximum of 507,759,303 shares, commencing on 14 October 2026 and concluding by 4 February 2027, subject to certain conditions. The buyback will be conducted externally through J.P. Morgan SE, adhering to regulatory conditions and daily volume limits.
TROO
TROOPS, Inc. has entered into a conditional sales and purchase agreement with EFFORCE Group, a blockchain infrastructure and sustainability-focused company co-founded by Steve Wozniak. The strategic merger aims to expand TROOPS' operational scope into digital verticals, including carbon credit and green certificate trading, enhancing its ability to serve institutional and commercial clients. The transaction is expected to provide a foundation for future growth, subject to customary closing conditions and regulatory approvals.
SA
Seabridge Gold Inc. agreed to acquire a 100% interest in the Slaughterhouse Project in southern Wyoming from Orogen Royalties Inc. The transaction includes a US$300,000 purchase price and up to US$2.55 million in milestone payments, subject to customary closing conditions. Orogen will retain a 2.5% net smelter return on existing claims and a 0.5% to 1% NSR royalty within a broader area of mutual interest. Seabridge's exploration team is optimistic about the potential for hematite iron oxide copper-gold deposits, which could enhance gold and critical metals exploration in the Western US.
CNL
Collective Mining Ltd. announced a significant discovery of high-grade silver-tungsten mineralization at the Apollo Deposit in Caldas, Colombia. The drilling program revealed 5.50 meters at 1,999 g/t AgEq in the Shallow Halo Zone, marking a substantial find northeast from OPad6 toward Pad35. Additional results include notable mineralization in nearby holes, underscoring the potential of the broader zone.
EUDAW
EUDA Health Holdings Limited is calling an extraordinary general meeting for October 30, 2026, to seek shareholder approval for significant corporate restructuring. The resolutions include changing the authorized share structure to an unlimited number of class A ordinary shares and 2,000,000 class B ordinary shares, and re-designating shares held by Tan Meng Dong and 8i Capital Limited as class B shares. The Board recommends voting "FOR" each proposal, with the Record Date set for October 8, 2026.
EDTK
Skillful Craftsman Education Technology Ltd agreed to acquire a 70% equity interest in URAY PTE LTD for $70 million, as per a Share Purchase Agreement signed on October 10, 2026. The deal involves the transfer of URAY's intangible assets, including game IPs and software copyrights, prior to the closing date. EDTK is required to comply with Nasdaq Listing Rules and U.S. federal securities laws for the private placement of ordinary shares in this transaction.
GP
GreenPower Motor Company Inc. has secured a strategic partnership to advance the development of 50 all-electric shuttle buses, backed by over $2.5 billion in funding for electric mobility projects. The collaboration aims to expand GreenPower's market reach beyond the United States and Canada, leveraging the EV Star Cab & Chassis's versatility and range. Victor Pliego has been retained to oversee the importation and body builds in Mexico, facilitating entry into new markets.
NRSNW
NeuroSense Therapeutics Ltd. secured compliance with Nasdaq's minimum bid price requirement, with its hearing scheduled for November 10, 2026, to address the $35 million market value deficiency. The company plans to present strategies to meet Nasdaq's requirements or the alternative stockholders' equity standard at the hearing. NeuroSense also anticipates filing its New Drug Submission for PrimeC in ALS with Health Canada by December 2026 and expects a decision on grant funding for the Phase 3 PARAGON trial in Q1 2027.
CHT
Chunghwa Telecom Co., Ltd. disclosed material developments in a 6-K filing on October 13, 2026. The company's subsidiary, CHT Intelligent Vision Solutions Co., Ltd., acquired right-of-use assets totaling NT$10.82 billion. Chunghwa Telecom reported unaudited September 2026 operating results with revenue of NT$24.40 billion and net income of NT$4.44 billion, marking increases compared to the same period in 2025.
IMRN
Immuron Limited announced in its October 13, 2026 Form 6-K filing that its Phase 2 clinical trial of Travelan showed a statistically significant 50% reduction in ETEC-related adverse events versus placebo (P=0.0001), alongside a 40% reduction in moderate-to-severe diarrhea and a 71% reduction in early antibiotic use. The trial, partially funded by the U.S. Department of Defense, demonstrated favorable efficacy trends despite not meeting primary endpoints due to a lower than anticipated placebo attack rate. Immuron is advancing Travelan as a non-antibiotic oral immunoprophylactic for bacterial diarrheal disease prevention, with additional data supporting its potential to enhance gut microbiome resilience.
SCNI
Scinai Immunotherapeutics Ltd. has executed a definitive development and clinical manufacturing agreement with a U.S.-based biopharmaceutical company, expanding its contracted CDMO business with committed base service fees of $5.1 million. Following the agreement, Scinai's Committed Customer Orders across its operations increased to approximately $7.6 million, a 300% rise from $1.9 million at year-end 2025. The services are expected to contribute to revenue during 2026 and 2027, with stability services continuing beyond
FSM
Fortuna Mining Corp. disclosed significant exploration results in its October 2026 Form 6-K report. At the Diamba Sud Gold Project in Senegal, reverse circulation and diamond drilling intersected multiple gold-rich zones, indicating potential expansion of the Mineral Reserve. Additionally, initial drilling at the newly acquired Bambadti properties showed promising mineralization, with an $8 million campaign planned for the remainder of 2026. Exploration at Kassasoko also intersected gold-rich zones beyond the current pit design, with further targets being refined for the 2027 field season.